Reozalimab

Names

[ CAS No. ]:
2445259-99-2

[ Name ]:
Reozalimab

Biological Activity

[Description]:

Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research[1][2].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1

[References]

[1]. Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12.

[2]. Reozalimab. IMGT/mAb-DB.

Chemical & Physical Properties

No Any Chemical & Physical Properties